384 related articles for article (PubMed ID: 30977453)
1. Recent Developments in Natural Product Inspired Synthetic 1,2,4- Trioxolanes (Ozonides): An Unusual Entry into Antimalarial Chemotherapy.
Tiwari MK; Yadav DK; Chaudhary S
Curr Top Med Chem; 2019; 19(10):831-846. PubMed ID: 30977453
[TBL] [Abstract][Full Text] [Related]
2. Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research.
Patel OPS; Beteck RM; Legoabe LJ
Eur J Med Chem; 2021 Mar; 213():113193. PubMed ID: 33508479
[TBL] [Abstract][Full Text] [Related]
3. Novel Peroxides as Promising Anticancer Agents with Unexpected Depressed Antimalarial Activity.
Coghi P; Yaremenko IA; Prommana P; Radulov PS; Syroeshkin MA; Wu YJ; Gao JY; Gordillo FM; Mok S; Wong VKW; Uthaipibull C; Terent'ev AO
ChemMedChem; 2018 May; 13(9):902-908. PubMed ID: 29469179
[TBL] [Abstract][Full Text] [Related]
4. Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold.
Rudrapal M; Chetia D
Drug Des Devel Ther; 2016; 10():3575-3590. PubMed ID: 27843298
[TBL] [Abstract][Full Text] [Related]
5. Ozonide Antimalarial Activity in the Context of Artemisinin-Resistant Malaria.
Giannangelo C; Fowkes FJI; Simpson JA; Charman SA; Creek DJ
Trends Parasitol; 2019 Jul; 35(7):529-543. PubMed ID: 31176584
[TBL] [Abstract][Full Text] [Related]
6. The comparative antimalarial properties of weak base and neutral synthetic ozonides.
Tang Y; Wittlin S; Charman SA; Chollet J; Chiu FC; Morizzi J; Johnson LM; Tomas JS; Scheurer C; Snyder C; Zhou L; Dong Y; Charman WN; Matile H; Urwyler H; Dorn A; Vennerstrom JL
Bioorg Med Chem Lett; 2010 Jan; 20(2):563-6. PubMed ID: 19962893
[TBL] [Abstract][Full Text] [Related]
7. Parasite-Mediated Degradation of Synthetic Ozonide Antimalarials Impacts
Giannangelo C; Stingelin L; Yang T; Tilley L; Charman SA; Creek DJ
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263074
[TBL] [Abstract][Full Text] [Related]
8. Novel series of 1,2,4-trioxane derivatives as antimalarial agents.
Rudrapal M; Chetia D; Singh V
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1159-1173. PubMed ID: 28870093
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic potential of semi-synthetic artemisinin and synthetic endoperoxide antimalarial agents.
O'Neill PM
Expert Opin Investig Drugs; 2005 Sep; 14(9):1117-28. PubMed ID: 16144496
[TBL] [Abstract][Full Text] [Related]
10. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
[TBL] [Abstract][Full Text] [Related]
11. Trioxaferroquines as new hybrid antimalarial drugs.
Bellot F; Coslédan F; Vendier L; Brocard J; Meunier B; Robert A
J Med Chem; 2010 May; 53(10):4103-9. PubMed ID: 20443628
[TBL] [Abstract][Full Text] [Related]
12. Synthetic Peroxides Promote Apoptosis of Cancer Cells by Inhibiting P-Glycoprotein ABCB5.
Yaremenko IA; Coghi P; Prommana P; Qiu C; Radulov PS; Qu Y; Belyakova YY; Zanforlin E; Kokorekin VA; Wu YYJ; Fleury F; Uthaipibull C; Wong VKW; Terent'ev AO
ChemMedChem; 2020 Jul; 15(13):1118-1127. PubMed ID: 32154637
[TBL] [Abstract][Full Text] [Related]
13. Artemisinin-derived antimalarial endoperoxides from bench-side to bed-side: Chronological advancements and future challenges.
Tiwari MK; Chaudhary S
Med Res Rev; 2020 Jul; 40(4):1220-1275. PubMed ID: 31930540
[TBL] [Abstract][Full Text] [Related]
14. Synthetic chemistry fuels interdisciplinary approaches to the production of artemisinin.
Corsello MA; Garg NK
Nat Prod Rep; 2015 Mar; 32(3):359-66. PubMed ID: 25342519
[TBL] [Abstract][Full Text] [Related]
15. Medicinal chemistry perspectives of trioxanes and tetraoxanes.
Kumar N; Sharma M; Rawat DS
Curr Med Chem; 2011; 18(25):3889-928. PubMed ID: 21824099
[TBL] [Abstract][Full Text] [Related]
16. Natural product-inspired aryl isonitriles as a new class of antimalarial compounds against drug-resistant parasites.
Kyei-Baffour K; Davis DC; Boskovic Z; Kato N; Dai M
Bioorg Med Chem; 2020 Oct; 28(19):115678. PubMed ID: 32912433
[TBL] [Abstract][Full Text] [Related]
17. Recent developments in antimalarial natural products isolated from medicinal plants.
Xu YJ; Pieters L
Mini Rev Med Chem; 2013 Jun; 13(7):1056-72. PubMed ID: 22974400
[TBL] [Abstract][Full Text] [Related]
18. Antimalarial Chemotherapy: Natural Product Inspired Development of Preclinical and Clinical Candidates with Diverse Mechanisms of Action.
Fernández-Álvaro E; Hong WD; Nixon GL; O'Neill PM; Calderón F
J Med Chem; 2016 Jun; 59(12):5587-603. PubMed ID: 26791529
[TBL] [Abstract][Full Text] [Related]
19. Comparative antimalarial activities and ADME profiles of ozonides (1,2,4-trioxolanes) OZ277, OZ439, and their 1,2-dioxolane, 1,2,4-trioxane, and 1,2,4,5-tetraoxane isosteres.
Wang X; Dong Y; Wittlin S; Charman SA; Chiu FC; Chollet J; Katneni K; Mannila J; Morizzi J; Ryan E; Scheurer C; Steuten J; Santo Tomas J; Snyder C; Vennerstrom JL
J Med Chem; 2013 Mar; 56(6):2547-55. PubMed ID: 23489135
[TBL] [Abstract][Full Text] [Related]
20. Antimalarial drug development: past to present scenario.
Dhanawat M; Das N; Nagarwal RC; Shrivastava SK
Mini Rev Med Chem; 2009 Oct; 9(12):1447-69. PubMed ID: 19929818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
